Royal Society of Chemistry, Analyst, 16(145), p. 5638-5646, 2020
DOI: 10.1039/d0an01066a
Full text: Unavailable
An evaluation of a rapid portable gold-nanotechnology measuring SARS-CoV-2 IgM, IgA and IgG antibody response to spike 1 (S1), spike 2 (S) and nucleocapsid (N) antigens using serum from 74 RNA(+) patients and RNA(+) 47 control patients.